Breca Tracy
Corporate Officer/Principal presso Heparinex LLC
Profilo
Dr. Breca Tracy is an Assistant Managing Director at Emergent Technologies, Inc.
She joined ETI in August of 2007 after obtaining her Ph.D.
in Biochemistry and Molecular Biology from the University of Oklahoma Health Sciences Center.
Her graduate work focused on the chemoenzymatic synthesis of glycosaminoglycan (GAG) oligosaccharides and characterization of protein/hyaluronan interactions.
She also holds a B.S.
from Stephens College.
Posizioni attive di Breca Tracy
| Società | Posizione | Inizio |
|---|---|---|
Heparinex LLC
 Heparinex LLC Pharmaceuticals: MajorHealth Technology Heparinex LLC operates as a biopharmaceutical company. It focuses on the novel recombinant synthesis of compounds for the anticoagulation market and associated markets and the dermal filler market. The firm maintains partnerships in the areas of medical device coatings; novel autoimmune and infectious disease and cancer drug discovery and dermal fillers. The company was founded in 2002 and is headquartered in Oklahoma City, OK. | Corporate Officer/Principal | - |
Precedenti posizioni note di Breca Tracy
| Società | Posizione | Fine |
|---|---|---|
Emergent Technologies, Inc.
 Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas. | Analista di Private Equity | 30/09/2017 |
Formazione di Breca Tracy
| Stephens College | Undergraduate Degree |
| University of Oklahoma | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Emergent Technologies, Inc.
Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas. | Finance |
Heparinex LLC
Heparinex LLC Pharmaceuticals: MajorHealth Technology Heparinex LLC operates as a biopharmaceutical company. It focuses on the novel recombinant synthesis of compounds for the anticoagulation market and associated markets and the dermal filler market. The firm maintains partnerships in the areas of medical device coatings; novel autoimmune and infectious disease and cancer drug discovery and dermal fillers. The company was founded in 2002 and is headquartered in Oklahoma City, OK. | Health Technology |
- Borsa valori
- Insiders
- Breca Tracy
